Christina Kuhn

Christina Kuhn provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.

Contact:

AI/IoT Update: The Potential Benefits of Digital Health Technology in Managing COVID-19

By Nigel Howard, Wade Ackerman & Christina Kuhn on March 27, 2020

Posted in Artificial Intelligence (AI), Innovation, Intellectual Property, Internet of Things (IoT)

The COVID-19 crisis is demonstrating the potential of digital health technology to manage some of our greatest public health challenges. The White House Office of Science and Technology Policy has issued a call to action for technology companies to help the science community answer high-priority scientific questions related to COVID-19. The Centers for Disease Control and Prevention has also recognized that technology and surveillance systems can play an integral role in supporting the public health response to outbreaks. …
Continue Reading AI/IoT Update: The Potential Benefits of Digital Health Technology in Managing COVID-19

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website. To exercise your right to opt-out of the sale or sharing of your personal information for targeted advertising purposes, click “reject.” Privacy Policy